Newbury Street Acquisition Corporation Announces Receipt of Nasdaq Letter
May 03, 2024 17:11 ET
|
Newbury Street Acquisition Corp
Boston, MA, May 03, 2024 (GLOBE NEWSWIRE) -- Newbury Street Acquisition Corporation (NASDAQ: NBST, the "Company") announced today that it received a letter dated April 24, 2024, from the Listing...
Compass Pathways to announce first quarter financial results on May 8, 2024
May 03, 2024 16:58 ET
|
Compass Pathways
LONDON, May 03, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health,...
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 03, 2024 16:45 ET
|
Praxis Precision Medicines, Inc.
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Summary Notice of Pendency and Proposed Settlement of Shareholder Derivative Actions
May 03, 2024 16:39 ET
|
Apple Inc.
CUPERTINO, Calif., May 03, 2024 (GLOBE NEWSWIRE) -- Apple Inc. has released the following notice: A Federal Court authorized this Notice. This is not a solicitation from a lawyer. TO: ALL PERSONS...
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 03, 2024 16:30 ET
|
Mersana Therapeutics, Inc.
CAMBRIDGE, Mass., May 03, 2024 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of...
Territorial Bancorp Inc. Announces First Quarter 2024 Results
May 03, 2024 16:30 ET
|
Territorial Bancorp Inc.
The Company’s tier one leverage and risk-based capital ratios were 11.58% and 28.84%, respectively, and the Company is considered to be “well-capitalized” at March 31, 2024.Ratio of non-performing...
Fate Therapeutics Announces Presentation of FT522 Preclinical Data for Autoimmune Diseases in Late-breaking Abstract at ASGCT Annual Meeting
May 03, 2024 16:30 ET
|
Fate Therapeutics, Inc.
Off-the-shelf, CD19-targeted CAR NK Cell Product Candidate Drives Rapid and Deep Depletion of SLE Donor CD19+ B cells ADR Technology Incorporated into FT522 Induces Functional Persistence and...
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 03, 2024 16:30 ET
|
ORIC Pharmaceuticals
SOUTH SAN FRANCISCO and SAN DIEGO, May 03, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address...
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 03, 2024 16:30 ET
|
Neuronetics
MALVERN, Pa., May 03, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Jayud Global Logistics Receives Nasdaq Notification of Non-Compliance with Listing Rule 5550(b)(1)
May 03, 2024 16:30 ET
|
Jayud Global Logistics Ltd
SHENZHEN, China, May 03, 2024 (GLOBE NEWSWIRE) -- Jayud Global Logistics Limited (NASDAQ: JYD) ("Jayud" or the "Company"), a leading end-to-end supply chain solution provider based in Shenzhen,...